[Sirolimus (Facial angiofibroma in tuberous sclerosis) - Assessment according to §35a (1), Sentence 11, Social Code Book V]

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018005577
German
Original Title: Sirolimus (Faziales Angiofibrom bei tuberöser Sklerose)
Details
Project Status: Completed
URL for project: https://www.iqwig.de/projekte/g23-28.html
Year Published: 2023
URL for published report: https://www.iqwig.de/download/g23-28_sirolimus_bewertung-35a-absatz-1-satz-11-sgb-v_v1-0.pdf
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
DOI: https://doi.org/10.60584/G23-28
MeSH Terms
  • Angiofibroma
  • Tuberous Sclerosis
  • Sirolimus
  • Immunosuppressive Agents
Keywords
  • Sirolimus
  • Angiofibroma
  • Tuberous Sclerosis
  • Health Care Costs
  • Epidemiology
Contact
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.